Login / Signup

Pharmacokinetics of a new human plasma-derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients.

Giancarlo CastamanAlessandra BorchielliniElena SantagostinoGiuseppe TagarielloMargit SerbanMarusia UscatescuCristina TruicaAlbert FarrugiaMassimo Morfini
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2019)
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • early onset
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes